Mark Lambrecht (@mlambrecht) 's Twitter Profile
Mark Lambrecht

@mlambrecht

#AI #datascience insights for patients, biopharma, agtech, hospitals and governments @SASSoftware | PhD Bioscience Eng. cell & gene #kuleuven | #badminton

ID: 14140173

linkhttps://www.sas.com/en/experts/mark-lambrecht.html calendar_today13-03-2008 15:38:23

4,4K Tweet

890 Followers

1,1K Following

Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

The SAS Life Sciences Community Connection will be back on Oct. 16 – 17. The virtual event is free and open to everyone using SAS in the pharmaceutical life cycle. Register today! 2.sas.com/6010WjMDy

The SAS Life Sciences Community Connection will be back on Oct. 16 – 17. The virtual event is free and open to everyone using SAS in the pharmaceutical life cycle. Register today!

2.sas.com/6010WjMDy
Eric Topol (@erictopol) 's Twitter Profile Photo

An exciting advance in Type 1 diabetes First person to receive her own stem cells, reprogrammed with transcription factors, to reverse it! Cell sciencedirect.com/science/articl… nature nature.com/articles/d4158…

An exciting advance in Type 1 diabetes
First person to receive her own stem cells, reprogrammed with transcription factors,  to reverse it!
<a href="/CellCellPress/">Cell</a> 
 sciencedirect.com/science/articl…
<a href="/Nature/">nature</a>
nature.com/articles/d4158…
Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

Pharma’s journey from molecule to market demands speed and precision. Modern data science is key to accelerating timelines and enhancing therapy quality. Discover insights by Soundarya Palanisamy in September’s PharmaTimes. Read the full article here: 2.sas.com/6019UJ3qc

Pharma’s journey from molecule to market demands speed and precision. Modern data science is key to accelerating timelines and enhancing therapy quality.

Discover insights by Soundarya Palanisamy in September’s PharmaTimes.

Read the full article here: 2.sas.com/6019UJ3qc
Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

Synthetic data can fill gaps in life science data sets and help address patient privacy and ethical concerns. How is your company addressing the opportunity to utilize synthetic #data generation in your business? Watch to learn more. 2.sas.com/6012UnHFG

Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

Dr. Greg Goldmacher from Merck weighs in on AI’s potential to enable diagnosis and opportunistic screening. #TheHealthPulse podcast. 2.sas.com/6015UZgOS

Dr. Greg Goldmacher from Merck weighs in on AI’s potential to enable diagnosis and opportunistic screening.  #TheHealthPulse podcast. 

2.sas.com/6015UZgOS
Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

Ready to embrace GenAI? Susan Lenderts, Global Head of Life Sciences at SAS, shares three crucial considerations for life sciences organizations. 2.sas.com/6018Ub1IY

Ready to embrace GenAI? Susan Lenderts, Global Head of Life Sciences at SAS, shares three crucial considerations for life sciences organizations. 

2.sas.com/6018Ub1IY
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
BensenHsu (@bensenhsu) 's Twitter Profile Photo

The Nobel Prize Their most renowned research: "The paper discusses the current understanding of how microRNAs function in the nematode Caenorhabditis elegans (C. elegans). Researchers have used C. elegans as a model organism to study microRNA biology and gain insights that are applicable to

<a href="/NobelPrize/">The Nobel Prize</a> Their most renowned research:

"The paper discusses the current understanding of how microRNAs function in the nematode Caenorhabditis elegans (C. elegans). Researchers have used C. elegans as a model organism to study microRNA biology and gain insights that are applicable to
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfield and Geoffrey E. Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.”

BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfield and Geoffrey E. Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.”
Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

Are Liquid Biopsies the Future of Cancer Biomarkers in Diagnosis or Monitoring of Disease? globalforum.diaglobal.org/issue/october-…

Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

We knew it to be true, but we love pointing to the proof! 👉 A Futurum Group analysis found SAS Viya helps users execute the life cycle of collecting data, building models, and deploying decisions 4.6x faster than selected competitors! 2.sas.com/6012qkDEr

Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

Analytics is crucial in the fight against cancer, enhancing care and diagnosis. The Centre Oscar Lambret is at the forefront, creating personalized care pathways for patients all while using SAS Viya. SAS Software 2.sas.com/6017Szzr5

Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

⚡ Help Carnegie Science investigators explore life, our planet, and the universe! give.carnegiescience.edu/campaign/66893…

Mark Lambrecht (@mlambrecht) 's Twitter Profile Photo

Roshan Shah, VP of Al at Georgia-Pacific and Bill Clifford, VP and General Manager for Unreal Engine at Epic Games, share how their companies have partnered with SAS to create simulations, resulting in more efficient, effective and safe workspaces. #SASInnovate #DigitalTwins